These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22473959)

  • 1. Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia.
    Lee K; Nam KT; Cho SH; Gudapati P; Hwang Y; Park DS; Potter R; Chen J; Volanakis E; Boothby M
    J Exp Med; 2012 Apr; 209(4):713-28. PubMed ID: 22473959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rictor/mammalian target of rapamycin 2 regulates the development of Notch1 induced murine T-cell acute lymphoblastic leukemia via forkhead box O3.
    Hua C; Guo H; Bu J; Zhou M; Cheng H; He F; Wang J; Wang X; Zhang Y; Wang Q; Zhou J; Cheng T; Xu M; Yuan W
    Exp Hematol; 2014 Dec; 42(12):1031-40.e1-4. PubMed ID: 25201756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors.
    Lee D; Sykes SM; Kalaitzidis D; Lane AA; Kfoury Y; Raaijmakers MH; Wang YH; Armstrong SA; Scadden DT
    Stem Cell Reports; 2014 Nov; 3(5):832-40. PubMed ID: 25418727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).
    García-Martínez JM; Alessi DR
    Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
    Julien LA; Carriere A; Moreau J; Roux PP
    Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
    Gulati N; Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
    Int J Oncol; 2009 Oct; 35(4):731-40. PubMed ID: 19724909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTORC2 negatively controls the maturation process of medullary thymic epithelial cells by inhibiting the LTβR/RANK-NF-κB axis.
    Liang Z; Zhang Q; Dong X; Zhang Z; Wang H; Zhang J; Zhao Y
    J Cell Physiol; 2021 Jun; 236(6):4725-4737. PubMed ID: 33269476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of mTOR complex 1 induces developmental blockage in early T-lymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells.
    Hoshii T; Kasada A; Hatakeyama T; Ohtani M; Tadokoro Y; Naka K; Ikenoue T; Ikawa T; Kawamoto H; Fehling HJ; Araki K; Yamamura K; Matsuda S; Hirao A
    Proc Natl Acad Sci U S A; 2014 Mar; 111(10):3805-10. PubMed ID: 24567410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.
    Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM
    J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
    Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
    J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer.
    Gulhati P; Cai Q; Li J; Liu J; Rychahou PG; Qiu S; Lee EY; Silva SR; Bowen KA; Gao T; Evers BM
    Clin Cancer Res; 2009 Dec; 15(23):7207-16. PubMed ID: 19934294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian target of rapamycin complex 2 modulates αβTCR processing and surface expression during thymocyte development.
    Chou PC; Oh WJ; Wu CC; Moloughney J; Rüegg MA; Hall MN; Jacinto E; Werlen G
    J Immunol; 2014 Aug; 193(3):1162-70. PubMed ID: 24981454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sin1 regulates Treg-cell development but is not required for T-cell growth and proliferation.
    Chang X; Lazorchak AS; Liu D; Su B
    Eur J Immunol; 2012 Jun; 42(6):1639-47. PubMed ID: 22678916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of rictor as a novel substrate of Polo-like kinase 1.
    Shao T; Liu X
    Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mTORC2 complex regulates terminal differentiation of C2C12 myoblasts.
    Shu L; Houghton PJ
    Mol Cell Biol; 2009 Sep; 29(17):4691-700. PubMed ID: 19564418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways.
    Lee K; Gudapati P; Dragovic S; Spencer C; Joyce S; Killeen N; Magnuson MA; Boothby M
    Immunity; 2010 Jun; 32(6):743-53. PubMed ID: 20620941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.
    Guertin DA; Stevens DM; Saitoh M; Kinkel S; Crosby K; Sheen JH; Mullholland DJ; Magnuson MA; Wu H; Sabatini DM
    Cancer Cell; 2009 Feb; 15(2):148-59. PubMed ID: 19185849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTORC2 regulates mechanically induced cytoskeletal reorganization and lineage selection in marrow-derived mesenchymal stem cells.
    Sen B; Xie Z; Case N; Thompson WR; Uzer G; Styner M; Rubin J
    J Bone Miner Res; 2014 Jan; 29(1):78-89. PubMed ID: 23821483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2.
    Boulbes D; Chen CH; Shaikenov T; Agarwal NK; Peterson TR; Addona TA; Keshishian H; Carr SA; Magnuson MA; Sabatini DM; Sarbassov dos D
    Mol Cancer Res; 2010 Jun; 8(6):896-906. PubMed ID: 20501647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options.
    Quesada AE; Nguyen ND; Rios A; Brown RE
    Int J Clin Exp Pathol; 2014; 7(12):8732-9. PubMed ID: 25674239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.